Showing 601-620 of 644 for: Cochrane Systematic Reviews > Psychiatric and substance abuse 
- Transcranial magnetic stimulation for treating depression
Cochrane Systematic Reviews, 22-Apr-2002
Transcranial magnetic stimulation can either excite or inhibit cortical areas of the brain, depending on whether the speed of the repetitive stimulation is applied at high or low frequencies. It has been used for physiological studies and it has also been
- Transcutaneous Electrical Nerve Stimulation (TENS) for dementia
Cochrane Systematic Reviews, 21-Jul-2003
Transcutaneous electrical nerve stimulation (TENS) is the application of an electrical current through electrodes attached to the skin. The commonest clinical application of TENS is pain control. TENS is also used occasionally for the treatment of a range
- Trazodone for agitation in dementia
Cochrane Systematic Reviews, 13-May-2008
Behavioural and psychiatric disturbances affect at least 50% of people with Alzheimer's disease and other dementias. Neuroleptic drugs are extensively prescribed to treat behavioural manifestations of dementia in spite of only modest efficacy and a high f
- Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)
Cochrane Systematic Reviews, 31-Oct-2008
Selective serotonin reuptake inhibitors are thought to have better discontinuation rates (i.e. less people dropping out) than tricyclic and heterocyclic antidepressant drugs. It is important to quantify the drop-out rates of different antidepressant drugs
- Treatment for amphetamine dependence and abuse
Cochrane Systematic Reviews, 15-Apr-2014
Amphetamine use is of concern because it causes a variety of devastating health physical and neurological consequences, including amphetamine-induced mental disorders.
- Treatment for amphetamine psychosis
Cochrane Systematic Reviews, 21-Jan-2009
Chronic amphetamine users may have experience of paranoia and hallucination. It has long been believed that dopamine antagonists, such as chlorpromazine, haloperidol, and thioridazine, are effective for the treatment of amphetamine psychosis.
- Treatment for amphetamine withdrawal
Cochrane Systematic Reviews, 15-Apr-2009
Few studies examined treatments for amphetamine withdrawal, although it is a common problem among amphetamine users. Its symptoms, in particular intense craving, may be a critical factor leading to relapse to amphetamine use. In clinical practice, medicat
- Treatment for inhalant dependence and abuse
Cochrane Systematic Reviews, 25-Oct-2010
Inhalants are being abused by large numbers of people throughout the world, particularly socio-economically disadvantaged children and adolescents. The neuropsychological effects of acute and chronic inhalant abuse include motor impairment, alterations in
- Treatment for Methaqualone dependence in adults
Cochrane Systematic Reviews, 27-Mar-2008
Methaqualone is a potent quinazoline, a class of sedative-hypnotics, that has a high potential for abuse. While the oral use of methaqualone (Quaalude, Mandrax) has waned in western countries since the mid-late 1980's, the practice of smoking methaqualone
- Treatment Foster Care for improving outcomes in children and young people
Cochrane Systematic Reviews, 1-May-2008
Treatment foster care (TFC) is a foster family-based intervention that aims to provide young people (and, where appropriate, their families) with a tailored programme designed to effect positive changes in their lives. TFC was designed specifically to cat
- Tricyclic and related drugs for nocturnal enuresis in children
Cochrane Systematic Reviews, 20-Jan-2016
Enuresis (bedwetting) affects up to 20% of five year-olds and 2% of adults. Although spontaneous remission often occurs, the social, emotional and psychological costs can be great. Tricyclics have been used to treat enuresis since the 1960s.
- Tricyclic drugs for depression in children and adolescents
Cochrane Systematic Reviews, 18-Jun-2013
There is a need to identify effective and safe treatments for depression in children and adolescents. While tricyclic drugs are effective in treating depression in adults, individual studies involving children and adolescents have been equivocal. Prescrib
- Trifluoperazine for schizophrenia
Cochrane Systematic Reviews, 26-Jan-2004
Trifluoperazine is an inexpensive accessible 'high potency' antipsychotic drug, widely used to treat schizophrenia or related psychoses.
- Tryptophan and 5‐Hydroxytryptophan for depression
Cochrane Systematic Reviews, 21-Jan-2002
5 Hydroxytryptophan (5-HTP) and tryptophan are so-called natural alternatives to traditional antidepressants, used to treat unipolar depression and dysthymia.
- Universal family-based prevention programs for alcohol misuse in young people
Cochrane Systematic Reviews, 27-Jul-2011
Alcohol misuse in young people is a cause of concern for health services, policy makers, prevention workers, and criminal justice system, youth workers, teachers, and parents.
- Universal multi-component prevention programs for alcohol misuse in young people
Cochrane Systematic Reviews, 27-Jul-2011
Alcohol misuse in young people is a cause of concern for health services, policy makers, prevention workers, and criminal justice system, youth workers, teachers, and parents.
- Universal school‐based prevention for illicit drug use
Cochrane Systematic Reviews, 1-Dec-2014
Drug addiction is a chronic, relapsing disease. Primary interventions should aim to reduce first use or to prevent the transition from experimental use to addiction. School is the appropriate setting for preventive interventions.
- Universal school-based prevention programs for alcohol misuse in young people
Cochrane Systematic Reviews, 3-Apr-2011
Alcohol misuse in young people is cause of concern for health services, policy makers, prevention workers, criminal justice system, youth workers, teachers, parents. This is one of three reviews examining the effectiveness of (1) school-based, (2) family-
- Use of electronic health records to support smoking cessation
Cochrane Systematic Reviews, 30-Dec-2014
Health information systems such as electronic health records (EHR), computerized decision support systems, and electronic prescribing are potentially valuable components to improve the quality and efficiency of clinical interventions for tobacco use.
- User-held personalised information for routine care of people with severe mental illness
Cochrane Systematic Reviews, 30-Sep-2013
It is important to seek cost-effective methods of improving the care and outcome of those with serious mental illnesses. User-held records, where the person with the illness holds all or some personal information relating to the course and care of their i
